This inventor holds 2 USPTO granted patents. Top assignees: Knoll Aktiengesellschaft, Leopold & Co., Chem. Pharm. Fabrik Aktiengesellschaft. Active years: 1991-1996.
Company Filing History:
1 out of 84 
1 out of 1 Years Active: 1991-1996
Title: Josef Polzer: Innovator in Pharmaceutical Emulsions and Cancer Therapy
Introduction
Josef Polzer is a notable inventor based in Graz, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable emulsions and compositions for cancer treatment. With a total of 2 patents, his work has the potential to impact therapeutic practices significantly.
Latest Patents
One of Polzer's latest patents is focused on a stable emulsion suitable for pharmaceutical administration. This invention describes an oil-in-water type emulsion that utilizes a phospholipid as an emulsifier. The active substance within this emulsion is hydrophobic, oil-soluble, and possesses a pKa of at least 7.5. The aqueous phase is maintained at an acidic pH, ensuring that the disperse phase achieves a positive zeta potential of at least +15 mV, ideally +30 mV, after dilution for administration.
Another significant patent involves a composition for destroying malignant tumors. This agent contains alpha-ketoglutaric acid and 5-hydroxymethylfurfural as active substances. It can be utilized in cancer therapy in various forms, including infusion solutions, oral or rectal administration, douches, or ointments.
Career Highlights
Throughout his career, Josef Polzer has worked with reputable companies such as Knoll Aktiengesellschaft and Leopold & Co., Chem. Pharm. Fabrik Aktiengesellschaft. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Polzer has collaborated with notable individuals in his field, including Karin Schaupp and Kurt Lanthaler. These partnerships have likely enriched his research and development efforts.
Conclusion
Josef Polzer's innovative work in pharmaceutical emulsions and cancer therapy showcases his commitment to advancing medical science. His patents reflect a deep understanding of complex chemical interactions and their applications in healthcare.